TABLE 2.
Effect of post-virus-exposure, i.p. T-1106 treatment on Syrian golden hamsters challenged with yellow fever virusa
Treatment | Beginning of treatment schedule (b.i.d, 8 days) | Result forb:
|
|||||
---|---|---|---|---|---|---|---|
Toxicity controls
|
Infected and treated
|
||||||
No. alive/total | Mean wt. changec (g) ± SDd | No. alive/total | MDDe ± SD | Mean serum ALT concn (IU/liter) ± SD | Mean wt changec (g) ± SD | ||
Expt 3 | |||||||
T-1106 (100 mg/kg/day) | −4 h | 3/3 | 8.0 ± 2.8 | 10/10*** | >21 ± 0.0*** | 58 ± 2.6*** | 6.0 ± 4.0** |
1 dpi | —f | — | 10/10*** | >21 ± 0.0*** | 56 ± 5.7*** | 6.1 ± 5.4** | |
2 dpi | — | — | 10/10*** | >21 ± 0.0*** | 57 ± 7.4*** | 6.3 ± 2.2*** | |
3 dpi | — | — | 10/10*** | >21 ± 0.0*** | 79 ± 23 | 2.9 ± 4.5** | |
Ribavirin (50 mg/kg/day) | −4 h | — | — | 7/8** | 6.0 ± 0.0 | 120 ± 52 | 1.3 ± 4.0* |
Saline | −4 h | 3/3 | 4.0 ± 2.6 | 2/10 | 6.8 ± 1.0 | 168 ± 115 | −4.9 ± 6.9 |
Normal control | — | 3/3 | 6.7 ± 4.0 | — | — | — | — |
Expt 4 | |||||||
T-1106 (100 mg/kg/day) | −4 h | — | — | 10/10*** | >21 ± 0.0*** | 55 ± 8.1** | 7.2 ± 2.1** |
4 dpi | — | — | 7/10** | 6.0 ± 0.0 | 108 ± 42 | −4.7 ± 8.8 | |
5 dpi | — | — | 2/10 | 7.4 ± 0.9 | 205 ± 81 | −6.9 ± 4.2 | |
Ribavirin (50 mg/kg/day) | −4 h | — | — | 9/10*** | 9.0 ± 0.0 | 98 ± 17** | 4.1 ± 2.5** |
Saline | −4 h | — | — | 1/10 | 7.0 ± 1.2 | 183 ± 69 | −5.2 ± 5.0 |
Normal control | — | 3/3 | 7.7 ± 1.2 | — | — | — | — |
Jimenez strain (10 CCID50/animal).
***, P ≤ 0.001, **, P ≤ 0.01, and *, P < 0.05, compared with saline-treated controls.
Difference between weights on 3 and 6 dpi.
Standard deviation was derived from a single experiment with the number of animals indicated in “No. alive/total” column.
MDD, mean day to death of hamsters dying prior to 21 dpi.
—, not applicable.